Mobile Menu

Search Results

Search results for: Drug Discovery

How to leverage genetics and advanced analytics for target discovery – insights from John Whittaker, GSK

Our D4 Global virtual event took place on 13th-16th October 2020. D4 Global was the world’s first truly global event […]

New class of precision oncology drug strips cancer of its DNA defences

Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]

Early results from the UK Biobank Exome Sequencing Consortium

The UK Biobank Exome Sequencing Consortium has released, as preprint in medRxiv, early results from the exome sequencing data generated […]

Genomics week in brief: Week ending 14th November

Your weekly summary of recent genomics news and research! Top stories from the past week Stanford researchers have developed a […]

Single Cell ONLINE November webinar series

Nearly all of the body’s functions are based on cellular heterogeneity – from complex neurobiological functions, to the development of […]

Genomics: Not all doom and gloom

In the past Genomics has faced a lot of controversy, particularly in relation to eugenics. Even today, applications of genomics, […]

Biologically-validated AI is how scientists are realising the full potential of single-cell RNA sequencing

The promise of single-cell gene expression data Genomic data are an excellent source of novel disease biomarkers and targets. In […]

Pharma stakeholders to progress data-driven development at D4 Global

Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]

Single Cell ONLINE – A virtual series

The human body has 40 trillion cells and roughly 200 different cell types. Amongst the diverse cell types lies incredible […]

ICR and Cancer Research UK spinout launches library of anti-cancer compounds

Monte Rosa Therapeutics is a spin-out formed by Versant Ventures, The Institute of Cancer Research (ICR) and Cancer Research UK […]